Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Levitt

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
The Journal of Clinical Psychiatry|July 17, 2012
A randomized controlled trial of psychoeducation or cognitive-behavioral therapy in bipolar disorder: a Canadian Network for Mood and Anxiety treatments (CANMAT) study [CME]Sagar V Parikh, Ari Zaretsky, Serge Beaulieu, et al.
Contemporary Clinical Trials Communications|July 9, 2020
Nitrous oxide as a putative novel dual-mechanism treatment for bipolar depression: Proof-of-concept study design and methodologyMikaela K Dimick, Danielle Omrin, Bradley J MacIntosh, et al.
Biological Psychiatry|August 26, 2024
Long-Term Safety and Efficacy of Focused Ultrasound Capsulotomy for Obsessive-Compulsive Disorder and Major Depressive DisorderClement Hamani, Benjamin Davidson, Jennifer S Rabin, et al.
Bipolar Disorders|December 29, 2022
Proof-of-concept randomized controlled trial of single-session nitrous oxide treatment for refractory bipolar depression: Focus on cerebrovascular target engagementWilliam S H Kim, Mikaela K Dimick, Danielle Omrin, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
The Journal of Clinical Psychiatry|July 17, 2012
A randomized controlled trial of psychoeducation or cognitive-behavioral therapy in bipolar disorder: a Canadian Network for Mood and Anxiety treatments (CANMAT) study [CME]Sagar V Parikh, Ari Zaretsky, Serge Beaulieu, et al.
Contemporary Clinical Trials Communications|July 9, 2020
Nitrous oxide as a putative novel dual-mechanism treatment for bipolar depression: Proof-of-concept study design and methodologyMikaela K Dimick, Danielle Omrin, Bradley J MacIntosh, et al.
Biological Psychiatry|August 26, 2024
Long-Term Safety and Efficacy of Focused Ultrasound Capsulotomy for Obsessive-Compulsive Disorder and Major Depressive DisorderClement Hamani, Benjamin Davidson, Jennifer S Rabin, et al.
Bipolar Disorders|December 29, 2022
Proof-of-concept randomized controlled trial of single-session nitrous oxide treatment for refractory bipolar depression: Focus on cerebrovascular target engagementWilliam S H Kim, Mikaela K Dimick, Danielle Omrin, et al.
Pageof 7